BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schønfeldt Troelsen F, Sørensen HT, Pedersen L, Erichsen R. Risk of a post-colonoscopy colorectal cancer diagnosis in patients with inflammatory bowel disease: a population-based cohort study. Endoscopy 2021;53:1023-33. [DOI: 10.1055/a-1322-6574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Kiesslich R. SCENIC update 2021: Is chromoendoscopy still standard of care for inflammatory bowel disease surveillance? Gastrointest Endosc 2022;95:38-41. [PMID: 34801222 DOI: 10.1016/j.gie.2021.10.009] [Reference Citation Analysis]
2 Burr NE. Interpreting post-colonoscopy colorectal cancer rates in inflammatory bowel disease. Endoscopy 2021. [PMID: 34284499 DOI: 10.1055/a-1395-7536] [Reference Citation Analysis]
3 Ahmad A, Dhillon A, Saunders BP, Kabir M, Thomas-gibson S. Validation of post-colonoscopy colorectal cancer (PCCRC) cases reported at national level following local root cause analysis: REFLECT study. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2021-102016] [Reference Citation Analysis]
4 Kiesslich R. Colour me blue: chromoendoscopy and advanced detection methods in ulcerative colitis. Curr Opin Gastroenterol 2022;38:67-71. [PMID: 34871195 DOI: 10.1097/MOG.0000000000000802] [Reference Citation Analysis]